Paper · 10691919
Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
Kudeken N and 2 others. Clin Exp Immunol, 2000. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Papers, record 10691919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10691919
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Granulocyte-Macrophage Colony-Stimulating Factor | Major topic |
| Neutrophil Activation | Major topic |
| Neutrophils | Major topic |
| Penicillium | Major topic |
| Antifungal Agents | |
| Cells, Cultured | |
| Humans |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,912,350 | Disseminated Penicillium marneffei infection in southeast Asia. | Lancet | 1994 | https://conductscience.org/library/papers/7912350 | PubMed |
| 2 | 8,307,142 | In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. | Eur J Epidemiol | 1993 | https://conductscience.org/library/papers/8307142 | PubMed |
| 3 | 8,643,813 | Fungal infections: a growing threat. | Public Health Rep | 1996 | https://conductscience.org/library/papers/8643813 | PubMed |
| 4 | 8,641,399 | Antibiotic proteins of polymorphonuclear leukocytes. | Eur J Haematol | 1996 | https://conductscience.org/library/papers/8641399 | PubMed |
| 5 | 8,702,012 | Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. | Am J Trop Med Hyg | 1996 | https://conductscience.org/library/papers/8702012 | PubMed |
| 6 | 8,971,625 | Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. | J Med Vet Mycol | 1996 | https://conductscience.org/library/papers/8971625 | PubMed |
| 7 | 8,975,924 | Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide. | Infect Immun | 1997 | https://conductscience.org/library/papers/8975924 | PubMed |
| 8 | 9,038,306 | Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. | Infect Immun | 1997 | https://conductscience.org/library/papers/9038306 | PubMed |
| 9 | 9,067,519 | CD4+ T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei. | Clin Exp Immunol | 1997 | https://conductscience.org/library/papers/9067519 | PubMed |
| 10 | 9,649,193 | Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages. | Clin Exp Immunol | 1998 | https://conductscience.org/library/papers/9649193 | PubMed |
1 to 10 of 35
See all 35 referencesCited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,257,635 | Clinical spectrum of Talaromyces marneffei infections in HIV-negative patients: an 18-case series including a rare presentation with gastrointestinal onset, adrenal mass, and hemophagocytic lymphohistiocytosis. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41257635 | PubMed |
| 37,055,706 | Clinical Characteristics, Course, and Long-Term Outcomes in Patients with Talaromyces marneffei Infection: A 10-Year Retrospective Cohort Study. | Infect Dis Ther | 2023 | https://conductscience.org/library/papers/37055706 | PubMed |
| 35,205,954 | Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms. | J Fungi (Basel) | 2022 | https://conductscience.org/library/papers/35205954 | PubMed |
| 34,512,824 | Clinical characteristics and risk factors of Talaromyces marneffei infection in human immunodeficiency virus-negative patients: A retrospective observational study. | World J Emerg Med | 2021 | https://conductscience.org/library/papers/34512824 | PubMed |
| 33,499,053 | The Host Immune Response to Scedosporium/Lomentospora. | J Fungi (Basel) | 2021 | https://conductscience.org/library/papers/33499053 | PubMed |
| 30,429,975 | 7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity. | Medchemcomm | 2018 | https://conductscience.org/library/papers/30429975 | PubMed |
| 28,884,011 | Adaptation to macrophage killing by Talaromyces marneffei. | Future Sci OA | 2017 | https://conductscience.org/library/papers/28884011 | PubMed |
| 27,224,737 | Talaromyces marneffei laccase modifies THP-1 macrophage responses. | Virulence | 2016 | https://conductscience.org/library/papers/27224737 | PubMed |
| 16,418,525 | Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/16418525 | PubMed |
| 11,349,055 | Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor. | Infect Immun | 2001 | https://conductscience.org/library/papers/11349055 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSF2 | 1,437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| SOD1 | 6,647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10691919
GET https://conductscience.org/api/papers/v1/10691919/references?page=2